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LETTER TO THE EDITOR
Porphyria and hepatocellular carcinoma
Sir - A recent short communication from Scandinavia
(Bengtsson & Hardell, 1986) draws attention again to the
unusual prevalence of hepatocellular cancer in patients with
porphyria. Their speculation that point mutations,
responsible for the enzymatic defects leading to the various
porphyrias could be associated with an oncogene is as
interesting as the other theory that porphyrins are
carcinogenic. A third possibility should be kept in mind, viz.
that the hepatocellular carcinoma produces a heme precursor
mimicking some of the biochemical findings characteristic of
porphyria. We described such a patient (Pierach et al., 1984)
in whom a hepatocellular carcinoma produced large amounts
of porphobilinogen. The patient did not suffer from
symptoms attributable to any of the known porphyrias.
Thus we considered this pseudo-porphyria to be a
paraneoplastic phenomenon and not a syndrome.
We think the connection between tumours and heme
synthesis is a most interesting and promising one, meriting
close observation and investigation.
Yours etc.,
C.A. Pierach,
Watson Laboratory,
University of Minnesota &
Abbott Northwestern Hospital,
800 East 28th Street at Chicago Avenue,
Minneapolis, Minnesota 55407 USA.
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